The effective inhibitory impact of Pc(4-4) is demonstrated via abrogation of PAR2-PH-Akt association, in vitro, and ovarian cancer peritoneal growth dissemination, in vivo. The gene discussed is F2RL1; the disease is ovarian cancer.